Mechanisms of Autophagy and Inflammatory Response Crosstalk in Sepsis‐Associated Intestinal Dysfunction
Annals of the New York Academy of Sciences · 2026-03 · 1557 (1)
DOI: 10.1111/nyas.70243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, online erschienen am 16.03.2026. Verfasst von He Man und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, People's Hospital of Suzhou New District, Suzhou, China. Hauptthemen laut MEDLINE: Autophagy, Sepsis, Inflammation, Intestinal Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Scientific Innovation Fund of People's Hospital of Suzhou New District, Medical Science and Technology Project of Suzhou New District, Technology Development Project of Suzhou City.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐associated intestinal dysfunction (SAID) drives multiorgan failure through dysregulated autophagy–inflammation crosstalk, for which effective therapies remain limited. This review systematically delineates SAID pathophysiology, evaluates preclinical and clinical evidence for autophagy‐targeted interventions, and explores emerging intestinal‐specific therapeutic targets. Autophagy preserves intestinal barrier integrity by clearing damaged organelles and suppressing NLRP3 inflammasome activation, whereas inflammatory mediators such as TNF‐α/IL‐6 and reactive oxygen species impair autophagic flux via Beclin‐1 destabilization and lysosomal dysfunction, establishing a pathogenic vicious cycle. Preclinical evidence demonstrates that rapamycin and TFEB agonists enhance autophagy, while ATG5 overexpression and NLRP3 siRNA restore epithelial homeostasis. Clinically, IL‐1 receptor antagonists have demonstrated efficacy in specific sepsis subpopulations. Stage‐specific therapeutic optimization is essential, as interventions must be tailored to the hyperinflammatory versus immunoparalysis phases. Novel intestinal‐barrier‐specific targets—including aquaporin‐3 (AQP3), ghrelin, and Nur77—emerge as key regulators of the autophagy−inflammation axis and represent promising therapeutic candidates. Targeting autophagy−inflammation crosstalk holds significant therapeutic potential, though clinical translation requires human‐relevant models and precision medicine approaches to address disease heterogeneity and stage‐specific pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, People's Hospital of Suzhou New District, Suzhou, China.
- Department of General Surgery, People's Hospital of Suzhou New District, Suzhou, China.
- The First Clinical Medical College of Lanzhou University, Lanzhou, China.
Förderung
- Scientific Innovation Fund of People's Hospital of Suzhou New District
- Medical Science and Technology Project of Suzhou New District
- Technology Development Project of Suzhou City
- Natural Science Foundation of Gansu Province
Zitieren
APA
Man, H., Yi, S., & Chen, C. (2026). Mechanisms of Autophagy and Inflammatory Response Crosstalk in Sepsis‐Associated Intestinal Dysfunction. Annals of the New York Academy of Sciences, 1557(1). https://doi.org/10.1111/nyas.70243
Vancouver
Man H, Yi S, Chen C. Mechanisms of Autophagy and Inflammatory Response Crosstalk in Sepsis‐Associated Intestinal Dysfunction. Annals of the New York Academy of Sciences. 2026;1557(1). doi:10.1111/nyas.70243
BibTeX
@article{Man2026,
author = {Man, He and Yi, Sun and Chen, Chai},
title = {Mechanisms of Autophagy and Inflammatory Response Crosstalk in Sepsis‐Associated Intestinal Dysfunction},
journal = {Annals of the New York Academy of Sciences},
year = {2026},
volume = {1557},
number = {1},
doi = {10.1111/nyas.70243}
}
EUVIMED